Skip to main content

A case of syphilis associated with immune reconstitution inflammatory syndrome and review of the literature



Immune reconstitution inflammatory syndrome (IRIS) associated with syphilis has rarely been described in HIV-infected patients. Diagnosis can be challenging because it is not always possible to discern it from a recent infection or a worsening of an undiagnosed one.

Case presentation

An HIV-positive 42-year-old man with a poor compliance history of antiretroviral therapy presented at our unit and complained of ocular symptoms. Ocular syphilis diagnosis was posed after initial misdiagnosing with cytomegalovirus infection, and antiretroviral therapy compliance improved after switching to a bictegravir-based regimen. Despite intravenous (IV) penicillin, we observed an initial worsening with the appearance of new skin lesions, and IRIS syphilis was suspected. In the literature, 14 cases of IRIS syphilis are described, all regarding male patients. Seven were HIV naïve to therapy, and 7 HIV-experienced with poor therapy compliance. Basal syphilis serology was negative in ten, with subsequent seroconversion after the development of IRIS. IRIS-syphilis development was observed after a median time of 28 days from ART initiation; 10 cases were considered "unmasking-IRIS" and 4 "paradoxical-IRIS". Skin and ocular involvement were the most often reported. In most cases, it was not necessary to use a systemic steroid. A good outcome was reported in 12.


Syphilis should be considered in differential diagnosis with other diseases associated with IRIS. A negative syphilis serology before beginning antiretroviral therapy could convey the impression that syphilis has been ruled out. Whereas a high index of suspicion should be maintained when symptoms suggestive of syphilis, such as ocular and skin manifestations, are noticed after therapy has begun.


Immune reconstitution inflammatory syndrome (IRIS) is a condition during the clinical course of HIV infection in which there is a paradoxical worsening or new onset of opportunistic infections in an HIV-positive patient following the initiation of antiretroviral therapy (ART) or switching to more potent ART regimen [1]. “Unmasking IRIS” is defined as a new appearance of symptoms related to an unknown infection, and “paradoxical IRIS” is defined as the worsening of a previously noted [2]. IRIS has rarely been reported in the context of syphilis infection [3].

Case presentation

An HIV-positive 42-year-old man with a history of poor compliance to antiretroviral therapy presented in February 2022 with blurry vision, ocular pain, and photophobia in the left eye. He denied sexual encounters except oral in the past six months. He was on ART with boosted darunavir, tenofovir alafenamide and emtricitabine, but he was not taking the therapy regularly. CD4 count was 196 cells/μl (9%), and HIV viral load was 258 copies/ml. Left eye examination showed uveitis, and ocular cytomegalovirus infection was suspected. Valganciclovir was promptly started, and ART was switched to a bictegravir-based regimen with adherence improvement. Two weeks later, he presented with worsening symptoms and complaints of contralateral eye involvement and was hospitalized. His blood exams were unremarkable, except for C reactive protein (15 mg/l – normal <5) on admission. Specific luetic serology was positive with rapid plasma reagin (RPR) 1:32 and a precedent negative, while cytomegalovirus viral load on blood was negative. Valganciclovir was discontinued, and Penicillin G 3 million units iv q4h plus ocular steroid were administered because of ocular involvement. A cerebral CT scan and MRI highlighted bilateral sclera enhancement. Lumbar puncture showed 130 cells/μl, increased cerebrospinal fluid (CSF) total protein levels (729 mg/dl, range 150-450 mg/dl), and the glucose value was normal.

Polymerase chain reaction for Treponema pallidum and RPR on liquor were both negative. Despite the therapy for syphilis, during the first week, he experienced a worsening of general clinical conditions associated with an increase in CD4 count (318 cells/μl) and a reduction in HIV-RNA (42 cp/ml). He developed desquamating papules on the scalp, back, soles and palms, patchy alopecia, eyebrow loss and the appearance of neck, axillary and inguinal lymphadenopathy. In the following days, the patient improved; he had ocular symptoms resolution at six months from discharge.

Discussion and conclusions

We considered our case a “paradoxical IRIS” because we observed a worsening of symptoms and the appearance of new lesions. At the first presentation, the worsening of symptoms with the involvement of the contralateral eye was related to the misdiagnosis. The second time the patient was on specific therapy with IV penicillin instead. The condition resolved without the necessity of steroids or other anti-inflammatory drugs.

The definition of IRIS-syphilis is complex as it is not always possible to discern it from a recent infection or a worsening of an undiagnosed one. Syphilis syndromes have rarely been described in the context of immune reconstitution, and only a few cases have been reported in the literature [3]. A computerized search was performed without language restriction using PubMed, SCOPUS and Web of Science™ for all cases of IRIS-syphilis from database inception until April 2022.

Our review using PubMed, SCOPUS and Web of Science™ (Figure 1) showed only 14 cases of IRIS associated with syphilis described in the literature. The cases were divided into "unmasking syphilis", characterized by a new appearance of syphilis symptoms after ART initiation, and "paradoxical syphilis", characterized by worsening previously present symptoms.

figure 1

Research of literature: identification of cases, screening, and inclusion

Epidemiological data and HIV status information are analytically shown in Table 1. Clinical characteristics of all the patients retrieved are analytically illustrated in Table 2, and investigations during IRIS, therapy and outcome are shown in Table 3. All patients were male with a 43-year-old median age (IQR 36 to 46). Of these cases, seven were concerned with HIV naïve to therapy patients and 7 with HIV infection known for years with poor compliance to ART. The HIV viral load at baseline was reported in 12 cases with a median value of 177,828 copies/ml (IQR 71,000 to 280,000 copies/ml), and CD4+ T lymphocytes count was reported in 14 cases prevalently lower than 200, with a median value of 91 cells/μl (interquartile range 25.5 to 163.5 cells/μl). The IRIS manifestations were associated with a reduction of HIV viral load by approximately three logarithms and to increase in CD4+ cell count.

Table 1 Epidemiological data and pre-IRIS data
Table 2 Type of IRIS and clinical manifestation
Table 3 Investigations during IRIS, therapy, and outcome

We classified 10 cases as “unmasking syphilis” and four as “paradoxical syphilis”. The median time for the development of IRIS after the beginning of ART was 28 days (IQR 13 to 46.5 days).

Skin and ocular manifestations were the most frequently described; all cases were compatible with secondary syphilis, and there were genital lesions in three.

A diagnosis of neurosyphilis/ocular syphilis was posed in 8 cases: six were characterized by ocular involvement and two by a neurological deficit. Ocular manifestations are diversified, and any component of the eye can be involved. The mostly disorders described were the reduction of visual acuity, scotomas, blurred vision, floaters, conjunctival injection, tearing, and eye pain. Neurological involvement was only in two cases with motor, language, and memory deficits appearance [5, 6]. Skin manifestations were heterogeneous and sometimes atypical. Braue et al describe a case of malignant syphilis characterized by necrotic warty lesions with a tumoral appearance whose histology initially set cutaneous lymphoma in the differential diagnosis [4]. Skin manifestations were associated with ocular involvement in four cases. The frequent ocular manifestation in these patients can be justified by immunocompromising that promotes the rapid spread of the pathogen. Lumbar puncture was performed in most cases, and CSF alterations were in a few, predominantly pleocytosis. Negative syphilis serology and or polymerase chain reaction usually was observed like in our case. Nevertheless, the absence of CSF alterations should never exclude neurosyphilis when clinical manifestations are suggestive. In all cases, the patients were not on ART either because they were naïve or because of inadequate adherence to therapy. We didn’t observe a particular ART regimen associated with IRIS syphilis, but most therapies were INSTI or protease-inhibitor based. ART induces restoration of a cellular immune response against Treponema pallidum antigens and may probably result in the progression toward exuberant clinical features of the disease [2]. In almost all cases, basal serology for syphilis was negative and became positive after IRIS manifestation. It can happen in an HIV-positive patient with less than 200 CD4+T cells because a humoral response does not develop or could be suppressed due to the dysfunction of CD4+T-cells [7]. It is plausible that the restoration of immune responses as a result of effective HIV-1 treatment triggers the unmasking of subclinical Treponema pallidum infection and subsequent seroconversion. On the other hand, a negative syphilis serology could be caused by the prozone phenomenon or the hook effect, in which an overabundance of an antigen led to a false-negative result [3, 8,9,10]. Treatment for IRIS syphilis does not differ from standard syphilis therapy, and steroid therapy would seem unnecessary. Systemic steroid use has been reported for a short period in a few cases.

In conclusion, our case and the others reported in the literature suggest that IRIS associated with syphilis should be considered when an unusual rash or ophthalmologic compromise appears after the ART initiation. A negative syphilis serology before beginning antiretroviral therapy could convey the impression that syphilis has been ruled out; a high index of suspicion should be maintained instead when symptoms suggestive of syphilis are noticed after treatment has begun.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.



Immune reconstitution inflammatory syndrome




Human immunodeficiency virus


Rapid plasma reagin


Computer tomography


Magnetic resonance imaging


Cerebrospinal fluid


Ribonucleic acid


Acquired immunodeficiency syndrome


Centers for Disease Control


Interquartile range


Integrase Strand Transfer Inhibitor


  1. Tappuni AR. Immune reconstitution inflammatory syndrome. Adv Dent Res. 2011;23(1):90–6.

    Article  CAS  PubMed  Google Scholar 

  2. Sereti I, et al. Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS. 2010;5(6):504–10.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mitra D, et al. A case of primary and secondary syphilis presenting together as immune reconstitution inflammatory syndrome. Indian J Sex Transm Dis AIDS. 2021;42(2):156–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Braue J, et al. A case of rupioid syphilis masquerading as aggressive cutaneous lymphoma. Mediterr J Hematol Infect Dis. 2015;7(1):e2015026.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rushing EJ, et al. Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity. J Neuropathol Exp Neurol. 2008;67(8):819–27.

    Article  PubMed  Google Scholar 

  6. Bucher JB, et al. Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy. Sex Transm Dis. 2011;38(5):442–4.

    Article  PubMed  Google Scholar 

  7. Yap FH, et al. A rare case of lues maligna with ocular involvement presenting as an unmasking immune reconstitution inflammatory syndrome in a patient with HIV infection. Australas J Dermatol. 2018;59(2):148–50.

    Article  PubMed  Google Scholar 

  8. Alcedo S, et al. Immune reconstitution inflammatory syndrome associated with secondary syphilis: dermatologic, neurologic and ophthalmologic compromise in an HIV patient. Int J STD AIDS. 2019;30(5):509–11.

    Article  PubMed  Google Scholar 

  9. Vasudevan B, et al. A rare case of secondary syphilis manifesting as immune reconstitution syndrome in an HIV-positive patient. J Int Assoc Provid AIDS Care. 2013;12(6):380–3.

    Article  PubMed  Google Scholar 

  10. Karp G, et al. Syphilis and HIV co-infection. Eur J Int Med. 2009;20(1):9–13.

    Article  Google Scholar 

  11. Frunza-Stefan S, et al. Immune reconstitution inflammatory syndrome associated with secondary syphilis. Int J STD AIDS. 2017;28(3):302–5.

    Article  PubMed  Google Scholar 

  12. Khatri A, Skalweit MJ. A rare case of immune reconstitution inflammatory syndrome presenting as secondary syphilis. Int J STD AIDS. 2015;26(10):749–51.

    Article  CAS  PubMed  Google Scholar 

  13. Bernal E, et al. “Panuveítis sifilítica en paciente con virus de la inmunodeficiencia humana tras reconstitución inmunológica” [Syphilitic panuveitis in an HIV-infected patient after immune restoration]. Enfermedades infecciosas y microbiologia clinica. 2009;27(8):487–9.

    Article  PubMed  Google Scholar 

  14. Hardwick C, et al. Montelukast in the treatment of HIV associated immune reconstitution disease. Sex Transm Infect. 2006;82(6):513–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Moloney G, et al. Syphilis presenting as scleritis in an HIV-positive man undergoing immune reconstitution. Clin Exp Ophthalmol. 2004;32(5):526–8.

    Article  PubMed  Google Scholar 

  16. Brochard J, et al. Immune reconstitution inflammatory syndrome presenting as secondary syphilis with polymorphous erythema and knee arthritis. J Eur Acad Dermatol Venereol: JEADV. 2017;31(8):e381–2.

    Article  CAS  PubMed  Google Scholar 

  17. Ceccarelli, Giancarlo; d’Ettorre, Gabriella.; Gizzi, Ftancesca et al. 2010. Ocular syphilis in an HIV-infected patient: Active disease or immune reconstitution syndrome? HAART Correl. Pathol. 7, 2 Accessed January 17, 2023.

Download references


This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations



LP and AM drafted the initial manuscript. LP, AM, and MT cured the data. LP, AM, MT, SB, and CG designed Fig. 1 and tables. CC, PD and AC critically revised the initial manuscript and contributed to manuscript writing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Antonio Cascio.

Ethics declarations

Ethics approval and consent to participate

Ethics approval not required.

Consent for publication

Written informed consent was obtained from the patient for the publication of this Case Report.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pipitò, L., Medaglia, A.A., Trizzino, M. et al. A case of syphilis associated with immune reconstitution inflammatory syndrome and review of the literature. AIDS Res Ther 20, 28 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: